TenQ · Equity ReportCharts view ⇢  Fact sheet  2026-05-10

CostcoCOST

$406.1B market cap

Classified by the SEC under retail-variety stores.

$915.74-16.2% from 52-week high · delayed close as of 2026-09-04 · not investment advice
-4.4% vs S&P 500 (SPY) +20.3% over twelve months
$820.84$912.98$1005$1097$1189Sep '25Nov '25Jan '26Apr '26Jun '26Sep '26
The verdict

Costco in 33 checks

Costco at a glance: how it scores on value, growth, quality, health, shareholder returns and trend. The fuller the shape, the stronger the company. Behind each axis are six pass-or-fail checks from its filings, spelled out in the chapters below. Point at an axis to see them.

VALUEGROWTHQUALITYHEALTHRETURNSTREND

A mixed picture - strengths and real weaknesses - 14 of 33 checks passed.

Advertisement
I

Value

●●●●●1/6

What you pay today for what the business produces, measured against COST's own history and its peers, never a universal rule.

Expensive against its own history and its sector - you're paying up for what you get.

46.1xown 5-year median 31x
1.4xown 5-year median 1x
2.2%cash earned per $ of price
28.4xwhole-business multiple
Today’s multiple

Is the price high or low right now, compared to what the market usually pays?

5-year median 31xP/E today 46.1x

At 46.1x earnings, the market is paying +48% more than COST's own 5-year median of 31.2x. Expectations are elevated, so more has to go right to justify the price.

Valuation history

What has the market paid for COST over the years?

0.0020.0040.002016202020212022202520265-year median 31.2xP/E 46.09

2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages

At 46.1x earnings, the market is paying +48% more than COST's own 5-year median of 31.2x. Expectations are elevated, so more has to go right to justify the price.

Free cash flow yield

What cash return does the business throw off per dollar of market value?

2.2%FCF yield today

0.0%2.0%4.0%2016202020212022202520265-year median 1.9%FCF yield 2.2%

2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages

At 2.2%, the business is throwing off more cash per dollar of market value than its own 5-year median of 1.9% - the cheaper end of its history.

What does “Value” actually mean?

Value asks what you pay for each dollar of earnings, sales or cash the business produces. A high multiple isn't automatically bad - fast growers earn theirs - but a price far above the company's own history means the market expects a lot to go right. We compare each multiple to the company's own past and to its sector, never to a universal rule.

How we scored it · 1 of 6 checks passed
Cheaper than its own history (earnings)46.09 vs 31.22
Earnings yield beats a long bond (4%)2.2% vs 4.0%
Better cash yield than its own history2.2% vs 1.9%
Free cash flow yield above 3%2.2% vs 3.0%
Cheap on enterprise value28.41 vs 14.00 (peer median)
Price isn't outrunning growthPEG 4.01
II

Growth

not scored

What the company has actually reported - is it selling more, and is more of it becoming profit?

Not enough data to score this fairly - the checks below show exactly what's missing.

Why there's no score: loss-making in both years; under 3 years of history; under 8 quarters of history.
-vs the year before
+6.6%compound annual
-net income growth
+11.5%compound annual
Revenue history

Revenue: is the business selling more than it used to?

0.00$200B200820092010201120142015201620202021202220252026$294B

◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year

Revenue reached $275.2B in 2025, compounding +7% a year since 2022 though the pace has cooled. The trailing twelve months are already running at $293.6B, ahead of the last full year.

Profit history

Net income: how much of that revenue becomes profit?

0.00$5.0B200820092010201120142015201620202021202220252026$8.8B

◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year

Net income was $8.1B in 2025, compounding +11% a year over three years. Trailing twelve-month profit stands at $8.8B.

Growth rate

How fast is it growing, year by year?

+21%revenue growth, FY 2025

0.0%50%200920102011201420152016202020212022202521%39%

In 2025 revenue grew +21% while earnings moved +39% - when the earnings line runs above revenue, each new dollar of sales is arriving more profitably.

Per-share growth

Revenue per share: is your slice growing as fast as the company?

$618.78revenue per share, FY 2025

0.0025050020082009201020112014201520162020202120222025202666019.80

2026 = trailing twelve months to the latest filed quarter (2026-05-10), not a full fiscal year

Revenue per share reached $618.78 in 2025, compounding +7% a year - in line with COST's own +7%, so the share count is not distorting your slice. Free cash flow per share stands at $17.62.

What does “Growth” actually mean?

Growth here is what the company has actually reported to the SEC - not a forecast. We look at the last year, the three-year pace, whether growth is speeding up or slowing down, and whether it's been consistent rather than one lucky year. Hatched bars are fourth quarters we derived from annual filings (companies file a full-year 10-K rather than a Q4 report).

How we scored it · 1 of 3 checks passed
Outgrew its sector last yearunder 8 quarters of history
Sustained growth beats its sector (3 years)6.6% vs 13.0% (market 70th pct)
Profits grew last yearloss-making in both years
Profit growth beats its peers11.5% vs 13.0% (market 70th pct)
Growth is speeding up, not slowingunder 3 years of history
Grew per share, not just in total21.3% vs 0.0%
III

Quality

●●●●●●4/6

Whether the growth makes real money - margins, returns on capital, and whether profits turn into cash.

A solidly profitable business, though not exceptional against its sector.

5.6%kept after direct costs
3.8%kept after running costs
26.4%profit on shareholders' money
25.3%against a 10% cost of capital
170%operating cash ÷ net income
Margins

Margins: of every $1 of sales, how much survives each cost layer?

0.0%2.0%4.0%2008200920102011201420152016202020212022202520263.8%3.0%

2026 = trailing twelve months to the latest filed quarter (2026-05-10), not a full fiscal year

Operating margin has held near 4% since 2022. After everything, 3 cents of each sales dollar reaches net profit. COST doesn't tag a gross-profit line in its filings, so the chart starts at operating margin.

Earnings quality

Earnings quality: do the reported profits turn into real cash?

0.00$10.0B200820092010201120142015201620202021202220252026$15.0B$8.8B

2026 = trailing twelve months to the latest filed quarter (2026-05-10), not a full fiscal year

Operating cash flow runs at 170% of reported profit, so the earnings are more than backed by cash - depreciation and other non-cash charges are understating what the business actually collects.

Returns on capital

What does it earn on the money it uses?

0.0%10%20%20082009201020112014201520162020202120222025202626%10%25%

2026 = trailing twelve months to the latest filed quarter (2026-05-10), not a full fiscal year

ROE 27% and ROCE 25% sit close together - the returns come from the business itself, not from borrowing.

Cash conversion

How much of every sales dollar ends up as free cash?

0.0%2.0%200820092010201120142015201620203.6%20212022202520263.0%

◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year

3 cents of every sales dollar became free cash in 2025, and it has held steady since 2022.

Spending intensity

What does staying competitive cost, per dollar of sales?

0.0%1.0%2.0%2008200920102011201420152016202020212022202520262.1%0.3%

2026 = trailing twelve months to the latest filed quarter (2026-05-10), not a full fiscal year

The biggest claim on each sales dollar is capital spending, at 2% of revenue (stock compensation 0%). That share has risen since 2022, so the cost of competing is climbing.

Operating leverage

When sales grow, do profits grow faster?

0.0%25%50%200920102011201420152016202020212022202521%33%

Operating profit outgrew revenue in 4 of the last 5 years, most recently +33% against +21%. Each additional dollar of sales is landing more profitably than the last - the definition of operating leverage.

Return on capital employed

Does COST earn more on its capital than that capital costs?

0.0%10%20%200920102011201420152016202020212022202510% cost-of-capital lineReturn on capital 25%

COST earns 25.3% on the capital it employs, well above the 10% most investors treat as the cost of capital. It was 23.6% in 2022, so the trend is up, and the pace is picking up. That is the highest in COST's filed history.

What does “Quality” actually mean?

Quality asks whether the growth makes real money. Margins show how much of each sale survives costs; return on equity shows what shareholders earn on their capital; and the profit-to-cash comparison catches companies whose accounting profits never turn into actual cash.

How we scored it · 4 of 6 checks passed
Better gross margins than peers5.6% vs 52.5% (market 70th pct)
Runs leaner than peers (operating margin)3.8% vs 13.0% (market 70th pct)
Actually profitableTTM net income $8.8B
Earns well on shareholders' money26.4% vs 12.3% (market 70th pct)
Earns a real return on the capital it employs25.3% vs 10.0%
Profits are cash, not accounting1.70 vs 0.80
IV

Health

●●●●●●4/6

The balance sheet stress test: could COST survive a bad year?

Financially sound overall, with one or two things worth watching.

0.17xborrowed vs owned
1.1xnear-term bills coverage
77xearnings ÷ interest bill
$20.0Bcash plus short-term investments
Debt & cash

Could it handle its debt if things went wrong?

0.00$10.0B$20.0B201220132014201520162017201820192020202120222023202420252026$5.7B$18.9B

2026 = the latest balance sheet (2026-05-10), not a fiscal year-end

The company holds $20.0B in cash against $5.7B of debt - a net-cash balance sheet, which means a bad year is an inconvenience rather than a threat.

Shareholders' equity

Is the company's own capital growing or shrinking?

0.00$20.0B201220132014201520162017201820192020202120222023202420252026$33.5B

The company's own capital grew from $26.1B in 2023 to $33.5B (+28%). The business is building book value rather than consuming it.

What does “Health” actually mean?

Health asks one question: can the business survive a bad year? We check whether near-term bills are covered, whether debt is modest and shrinking, whether earnings comfortably pay the interest, and - for loss-makers - how many years of cash are left at the current burn rate.

How we scored it · 4 of 6 checks passed
Comfortable near-term liquidity1.07 vs 1.50
Debt isn't dominating0.17 vs 1.00
Debt trending the right waydebt/equity 0.17 now vs 0.40 five years ago
Earnings cover the interest76.88 vs 5.00
Converts sales to cash better than its sector5.1% vs 20.5% (market 70th pct)
Self-fundingTTM free cash flow $8.8B
V

Shareholder returns

●●●●●●3/6

How much cash actually flows back to owners - dividends, buybacks, whether the share count truly falls, and whether what is handed back is affordable.

Cash comes back to owners, with a caveat or two in the checks below.

$3.2Bdividends plus buybacks
$2.2Blast fiscal year
$903Mlast fiscal year
$860Mdilutes the buybacks
+0.1%since 2008 (as reported)
Capital returned vs stock comp

How much goes back to shareholders - and how much leaks out as stock compensation?

0.00$2.5B$5.0B20082009201020112014201520162020202120222025

$3.1B returned last year against $860M of stock issued to employees - the returns outweigh the dilution 3.6-to-1.

Dilution rate (split-adjusted)

How fast is your ownership being diluted - or concentrated?

0.0%1.0%200920101.3%201120142015201620202021202220250.0%

0.0% more shares last year - your stake was diluted by that much.

Dividend per share (split-adjusted)

Is the dividend cheque itself growing?

0.005.0010.0020082009201020112014201520162020202120222025DPS 4.91

Down from $6.47 to $4.91 per share - the cheque has shrunk.

Dividend yield

What does the payout earn you at each year's prices?

0.0%2.0%201620202021202220252026Yield 0.5%

2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages

At today's price the yield is 0.5%.

Payout quality

Can it actually afford the dividend?

0.0%100%20082009201020112014201520162020202120222025202625%25%

2026 = trailing twelve months to the latest filed quarter (2026-05-10), not a full fiscal year

Comfortable: 27% of profits and 28% of free cash flow go out as dividends - well inside what the business generates.

Dilution against what it bought

COST has issued or retired shares - did shareholders end up better off?

020040020082009201020112014201520162020202120222025100379

Both lines start at 100 in 2008, so the gap between them is what each share gained or lost. Share counts are split-adjusted.

COST's share count has barely moved from 2008 to 2025, so growth has not been funded by issuing stock. Revenue per share is +279% over the same years.

Why compare buybacks with stock compensation?

A company can trumpet billions in buybacks while quietly issuing nearly as much stock to employees. What matters to you is the net effect: is the share count actually falling? If not, the 'return' is mostly recycling.

How we scored it · 3 of 6 checks passed
Share count isn't climbingshares up 0.0% over 3 years
Buybacks outpace the stock issued to staff$883M bought back vs $911M of stock compensation
What it hands back fits inside its cash flow36.2% vs 100.0%
Meaningful yield to owners (dividends and buybacks)$3.2B returned, 0.8% of market value
Reliable payer, never cutpaid 10/10 years, worst year-on-year change -74.0%
Dividend growing ahead of inflation47.6% vs 9.0%
VI

Trend analysis

●●●●●1/6

What the market is doing about all of the above. This is price behaviour, not a fact about the business - read it as the market's current opinion, scored on six checks like every other chapter. The market is the S&P 500, measured by the SPY ETF with dividends included, over 3 months (63 trading sessions) and 12 months (252).

The market is voting against it right now - a falling trend on most measures.

-4.4%the long-term trend line
-5.6%S&P 500 (SPY): +4.7%
-3.6%S&P 500 (SPY): +20.0%
-16.2%drawdown from peak
Trend

How is COST's trend actually behaving right now?

Price chart loads as you scroll…

Chart by TradingView

COST is in a downtrend. The price is below the band where recent trading settled and that band is still falling, so nothing in the picture has turned yet. It crossed only 3 sessions ago, so treat it as unsettled. Both the last two weeks and the month-ago comparison point down as well, so nothing here disagrees with the downtrend. The band drawn for the coming weeks turns downward partway through, so that support is set to thin out from there.

How the trend above is worked out

The trend read comes from the daily Ichimoku picture, a standard trend indicator, translated out of its jargon. It builds a band from the midpoints of the last 9, 26 and 52 sessions' highs and lows - in effect, the range where recent trading has settled - and draws that band 26 sessions into the future. Price above the band is an uptrend, below it a downtrend, inside it no trend. Because the band is drawn forward, the support for the next few weeks is already fixed and a change of its direction can be seen coming. We also compare the last two weeks against the last month, and today's price against where it stood a month ago. None of this says anything about the business; it describes the price only, and it is not advice. Where a check says 'the S&P 500', the comparison is with the SPY ETF including dividends, on the same adjusted basis as the stock's own price: short means 3 months, 63 trading sessions; long means 12 months, 252.

How we scored it · 1 of 6 checks passed
In an uptrend915.74 vs 957.90
Trend structure is healthy943.01 vs 957.90
Rising over 3 months-5.6% vs 0.0%
Beating the S&P 500 over 3 months-5.6% vs 4.7%
Beating the S&P 500 over 12 months-3.6% vs 20.0%
Not in a deep hole-16.2% from its 52-week high
VII

Insider activity

informational

What the people running the company do with their own shares - reported to the SEC within two days, classified so pay-plumbing doesn't masquerade as conviction.

$0.00their own money
$15Moften pre-scheduled
12of the last filings
48grants · exercises · tax
Open-market flow

Are the people running it buying or selling with their own money?

$4M$2M0.00Sep '25Oct '25Nov '25Dec '25Jan '26Mar '26Apr '26Jun '26

No open-market buying, and $15M of selling across 8 months. Selling alone is a weak signal - much of it is pre-scheduled - but the absence of buying tells you no insider saw the price as a bargain.

The record

Who did what, exactly?

DateInsiderRoleTypeSharesValue
2026-06-23Kenneth D DenmanDirectorSELL885$847,345
2026-04-01Caton FratesExecutive Vice PresidentSELL700$695,100
2026-03-12Sarah Catherine GeorgeExecutive Vice PresidentI642$636,483
2026-03-11Gary MillerchipExecutive Vice Presidenttax1,154$1M
2026-03-09Claudine AdamoExecutive Vice PresidentSELL730$732,205
2026-01-21Teresa A. JonesExecutive Vice PresidentSELL850$838,318
2026-01-16Susan L DeckerDirectorSELL458$437,390
2026-01-14James C KlauerExecutive Vice PresidentSELL1,500$1M
2026-01-09Russell D MillerSr. Executive Vice PresidentSELL1,500$1M
2025-12-30Javier PolitExecutive Vice PresidentSELL558$481,759
Why do the transaction types matter so much?

Most insider filings are not trades: stock grants, option exercises and tax withholding are how executives get paid, and gifts are estate planning. The signal lives in open-market transactions - a buy means an insider chose to spend their own cash on the stock. Sells are murkier: many are pre-scheduled 10b5-1 plans set months in advance. That's why the chart counts only open-market activity, and the table labels every row.

§

Recent filings

  • 10-Q Quarterly report
  • 10-Q Quarterly report
  • 10-Q Quarterly report
  • DEF 14A Proxy statement
  • 10-K Annual report
  • 10-Q Quarterly report
  • 10-Q Quarterly report
  • 10-Q Quarterly report
The TenQ weekly brief is coming.One email a week: the charts that mattered, nothing else.